Warning: count(): Parameter must be an array or an object that implements Countable in /home/customer/www/drugtrialsformoney.com/public_html/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 390

A Safety Study of SEA-TGT (SGN-TGT) in Advanced Cancer

A Safety Study of SEA-TGT (SGN-TGT) in Advanced Cancer
Conditions:   Non-small Cell Lung Cancer;   Gastric Carcinoma;   Gastroesophageal Junction Carcinoma;   Classical Hodgkin Lymphoma;   Diffuse Large B-cell Lymphoma;   Peripheral T-cell Lymphoma;   Cutaneous Melanoma;   Head and Neck Squamous Cell Carcinoma;   Bladder Cancer;   Ovarian Cancer;   Triple Negative Breast Cancer
Interventions:   Drug: SEA-TGT;   Drug: pembrolizumab
Sponsor:   Seagen Inc.
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

December 10, 2020 / by / in
Comments